Search results
Results from the WOW.Com Content Network
From fiscal 2024 to fiscal 2027, analysts expect Costco's revenue and EPS to grow at a CAGR of 7% and 11%, respectively. But like Walmart, Costco's stock isn't a bargain at 47 times next year's ...
Leuprorelin, also known as leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, for early puberty, or as part of transgender hormone therapy.
Clomipramine, sold under the brand name Anafranil among others, is a tricyclic antidepressant (TCA). [7] It is used in the treatment of various conditions, most notably obsessive–compulsive disorder but also many other disorders, including hyperacusis, panic disorder, major depressive disorder, trichotillomania, [8] body dysmorphic disorder [9] [10] [11] and chronic pain. [7]
A gonadotropin-releasing hormone agonist (GnRH agonist) is a type of medication which affects gonadotropins and sex hormones. [1] They are used for a variety of indications including in fertility medicine and to lower sex hormone levels in the treatment of hormone-sensitive cancers such as prostate cancer and breast cancer, certain gynecological disorders like heavy periods and endometriosis ...
In one corner, Walmart (NYSE: WMT) stock is having a banner year, up 54% amid a string of better-than-expected results. On the other side, Dollar General (NYSE: DG) has struggled to manage weak ...
For the 12th time in 50 years, Walmart will conduct a stock split in an effort to make shares more affordable for its employees. Walmart last carried out a 2-for-1 stock split on April 20, 1999.
Cetrorelix (INN Tooltip International Nonproprietary Name, BAN Tooltip British Approved Name), or cetrorelix acetate (USAN Tooltip United States Adopted Name, JAN Tooltip Japanese Accepted Name), sold under the brand name Cetrotide, is an injectable gonadotropin-releasing hormone (GnRH) antagonist.
With a price-to-earnings ratio of 37.5 and price-to-free cash flow (P/FCF) of more than 43, even Walmart's lower-priced stock looks quite expensive. This malaise extends beyond Costco and Walmart.